Phathom Pharmaceuticals, Inc. (PHAT)

13.19 +0.58 (+4.60%) USD  |  NASDAQ  |  Apr 17, 16:00
13.18 -0.01 (-0.08%) After-Hours: 20:00
More

Phathom Pharmaceuticals Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for PHAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Replimune Group, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
MannKind Corp. Upgrade
Ocugen, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade